Integral Health Asset Management
Latest statistics and disclosures from Integral Health Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INSM, CYTK, RVMD, VERA, REGN, and represent 30.09% of Integral Health Asset Management's stock portfolio.
- Added to shares of these 10 stocks: RVMD (+$64M), MDT (+$50M), ISRG (+$48M), REGN (+$43M), DXCM (+$33M), TEVA (+$31M), TFX (+$31M), RYTM (+$27M), MRK (+$26M), GKOS (+$25M).
- Started 23 new stock positions in SNDX, GOSS, MAZE, EYPT, UNH, SGHT, PRAX, CELC, BRKR, BCRX. VKTX, IKT, TFX, MRK, TEVA, BIIB, TNGX, GPCR, DXCM, SLNO, LNTH, EVMN, MNMD.
- Reduced shares in these 10 stocks: INSM (-$78M), THC (-$40M), NAMS (-$28M), NVO (-$22M), TERN (-$21M), MLYS (-$18M), CYTK (-$16M), BTSG (-$15M), PFE (-$13M), ELAN (-$12M).
- Sold out of its positions in ACHC, A, DYN, ESPR, EXAS, HOLX, IQV, JNJ, MCK, NVO. PFE, NAMS, PHVS.
- Integral Health Asset Management was a net buyer of stock by $325M.
- Integral Health Asset Management has $2.0B in assets under management (AUM), dropping by 36.25%.
- Central Index Key (CIK): 0001773206
Tip: Access up to 7 years of quarterly data
Positions held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 84 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 10.8 | $218M | -26% | 1.3M | 174.04 |
|
| Cytokinetics Com New Call Option (CYTK) | 6.0 | $121M | -11% | 1.9M | 63.54 |
|
| Revolution Medicines (RVMD) | 4.7 | $96M | +200% | 1.2M | 79.65 |
|
| Vera Therapeutics Cl A (VERA) | 4.5 | $91M | +5% | 1.8M | 50.64 |
|
| Regeneron Pharmaceuticals (REGN) | 4.0 | $81M | +110% | 105k | 771.87 |
|
| Medtronic SHS (MDT) | 3.2 | $65M | +350% | 675k | 96.06 |
|
| Intuitive Surgical Com New (ISRG) | 3.1 | $62M | +340% | 110k | 566.36 |
|
| Rhythm Pharmaceuticals (RYTM) | 2.5 | $51M | +115% | 475k | 107.04 |
|
| Alignment Healthcare (ALHC) | 2.2 | $44M | +37% | 2.2M | 19.75 |
|
| Cardinal Health (CAH) | 2.0 | $41M | +53% | 200k | 205.50 |
|
| CVS Caremark Corporation (CVS) | 2.0 | $40M | +150% | 500k | 79.36 |
|
| Edgewise Therapeutics (EWTX) | 1.8 | $37M | 1.5M | 24.82 |
|
|
| Glaukos (GKOS) | 1.8 | $37M | +225% | 325k | 112.91 |
|
| Mineralys Therapeutics Call Option (MLYS) | 1.8 | $36M | -33% | 1.0M | 36.29 |
|
| Novartis Sponsored Adr (NVS) | 1.7 | $35M | +25% | 250k | 137.87 |
|
| Dex (DXCM) | 1.6 | $33M | NEW | 500k | 66.37 |
|
| Astrazeneca Sponsored Adr | 1.6 | $32M | +16% | 350k | 91.93 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.5 | $31M | NEW | 1.0M | 31.21 |
|
| Penumbra (PEN) | 1.5 | $31M | +100% | 100k | 310.91 |
|
| Teleflex Incorporated (TFX) | 1.5 | $31M | NEW | 250k | 122.04 |
|
| Brightspring Health Svcs (BTSG) | 1.4 | $28M | -34% | 750k | 37.45 |
|
| Edwards Lifesciences (EW) | 1.4 | $28M | +62% | 325k | 85.25 |
|
| Centene Corporation (CNC) | 1.3 | $27M | +62% | 650k | 41.15 |
|
| Cooper Cos (COO) | 1.3 | $27M | +242% | 325k | 81.96 |
|
| Merck & Co (MRK) | 1.3 | $26M | NEW | 250k | 105.26 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $24M | 60k | 397.65 |
|
|
| Irhythm Technologies (IRTC) | 1.1 | $23M | +100% | 130k | 177.44 |
|
| Uniqure Nv SHS (QURE) | 1.1 | $22M | +50% | 900k | 23.93 |
|
| Eli Lilly & Co. (LLY) | 1.1 | $22M | 20k | 1074.68 |
|
|
| Boston Scientific Corporation (BSX) | 1.1 | $22M | -25% | 225k | 95.35 |
|
| Neurocrine Biosciences (NBIX) | 1.1 | $21M | 150k | 141.83 |
|
|
| Lifestance Health Group (LFST) | 1.0 | $21M | +100% | 3.0M | 7.04 |
|
| Anthem (ELV) | 1.0 | $21M | +20% | 60k | 350.55 |
|
| Upstream Bio (UPB) | 1.0 | $20M | +30% | 750k | 27.15 |
|
| Tenet Healthcare Corp Com New (THC) | 1.0 | $20M | -66% | 100k | 198.72 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.0 | $19M | +50% | 90k | 213.24 |
|
| Roivant Sciences SHS (ROIV) | 0.9 | $18M | +13% | 850k | 21.70 |
|
| Doximity Cl A (DOCS) | 0.9 | $18M | +122% | 400k | 44.28 |
|
| Biogen Idec (BIIB) | 0.9 | $18M | NEW | 100k | 175.99 |
|
| Regenxbio Inc equity us cm (RGNX) | 0.9 | $17M | +9% | 1.2M | 14.40 |
|
| Terns Pharmaceuticals (TERN) | 0.9 | $17M | -55% | 425k | 40.40 |
|
| Biohaven (BHVN) | 0.8 | $17M | +130% | 1.5M | 11.29 |
|
| UnitedHealth (UNH) | 0.8 | $17M | NEW | 50k | 330.11 |
|
| Tarsus Pharmaceuticals (TARS) | 0.8 | $16M | -20% | 200k | 81.88 |
|
| Fresenius Medical Care Sponsored Adr (FMS) | 0.8 | $16M | +44% | 650k | 23.82 |
|
| Beam Therapeutics (BEAM) | 0.8 | $15M | +37% | 550k | 27.72 |
|
| Soleno Therapeutics (SLNO) | 0.7 | $15M | NEW | 325k | 46.30 |
|
| RadNet (RDNT) | 0.7 | $14M | -33% | 200k | 71.35 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.7 | $13M | +200% | 300k | 44.05 |
|
| Arcellx Common Stock (ACLX) | 0.6 | $13M | +33% | 200k | 65.20 |
|
| Quest Diagnostics Incorporated (DGX) | 0.6 | $13M | -11% | 75k | 173.53 |
|
| Sana Biotechnology (SANA) | 0.6 | $12M | +50% | 3.0M | 4.07 |
|
| Protara Therapeutics Com Stk (TARA) | 0.6 | $12M | +60% | 2.3M | 5.33 |
|
| Praxis Precision Medicines I Com New (PRAX) | 0.6 | $12M | NEW | 40k | 294.74 |
|
| Dianthus Therapeutics (DNTH) | 0.6 | $11M | +83% | 275k | 41.21 |
|
| Envista Hldgs Corp (NVST) | 0.5 | $11M | -9% | 500k | 21.71 |
|
| Encompass Health Corp (EHC) | 0.5 | $11M | -50% | 100k | 106.14 |
|
| Oric Pharmaceuticals (ORIC) | 0.5 | $9.8M | +33% | 1.2M | 8.18 |
|
| Charles River Laboratories (CRL) | 0.4 | $9.0M | -25% | 45k | 199.48 |
|
| Celcuity (CELC) | 0.4 | $8.0M | NEW | 80k | 99.74 |
|
| Inspire Med Sys (INSP) | 0.3 | $6.9M | -37% | 75k | 92.23 |
|
| Alto Neuroscience Com Shs (ANRO) | 0.3 | $6.7M | -6% | 375k | 17.80 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.3 | $6.7M | NEW | 100k | 66.55 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.3 | $6.6M | -55% | 100k | 66.39 |
|
| Bruker Corporation (BRKR) | 0.3 | $5.9M | NEW | 125k | 47.11 |
|
| Nurix Therapeutics (NRIX) | 0.3 | $5.7M | -14% | 300k | 18.97 |
|
| Elanco Animal Health (ELAN) | 0.3 | $5.7M | -68% | 250k | 22.63 |
|
| Apellis Pharmaceuticals (APLS) | 0.2 | $5.0M | -20% | 200k | 25.12 |
|
| Rezolute Com New (RZLT) | 0.2 | $4.7M | 2.0M | 2.36 |
|
|
| Mind Medicine Mindmed Com New (MNMD) | 0.2 | $4.7M | NEW | 350k | 13.39 |
|
| Syndax Pharmaceuticals (SNDX) | 0.2 | $4.2M | NEW | 200k | 21.01 |
|
| Maze Therapeatics (MAZE) | 0.2 | $4.1M | NEW | 100k | 41.43 |
|
| Eyepoint Com New (EYPT) | 0.2 | $3.7M | NEW | 200k | 18.27 |
|
| Inhibikase Therapeutics Com New (IKT) | 0.2 | $3.6M | NEW | 1.8M | 2.05 |
|
| Viking Therapeutics (VKTX) | 0.2 | $3.5M | NEW | 100k | 35.18 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $3.5M | NEW | 50k | 69.55 |
|
| Sight Sciences (SGHT) | 0.2 | $3.4M | NEW | 425k | 7.93 |
|
| Gossamer Bio (GOSS) | 0.2 | $3.1M | NEW | 1.0M | 3.10 |
|
| Oscar Health Cl A (OSCR) | 0.1 | $2.9M | -63% | 200k | 14.37 |
|
| Lb Pharmaceuticals Com Shs (LBRX) | 0.1 | $2.2M | 100k | 22.26 |
|
|
| Evommune Com Shs (EVMN) | 0.1 | $2.1M | NEW | 125k | 17.12 |
|
| Tenax Therapeutics Com New (TENX) | 0.1 | $2.0M | 167k | 12.19 |
|
|
| Tango Therapeutics (TNGX) | 0.1 | $1.8M | NEW | 200k | 8.86 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.6M | NEW | 200k | 7.80 |
|
Past Filings by Integral Health Asset Management
SEC 13F filings are viewable for Integral Health Asset Management going back to 2019
- Integral Health Asset Management 2025 Q4 filed Feb. 17, 2026
- Integral Health Asset Management 2025 Q3 filed Nov. 14, 2025
- Integral Health Asset Management 2025 Q2 filed Aug. 14, 2025
- Integral Health Asset Management 2025 Q1 filed May 15, 2025
- Integral Health Asset Management 2024 Q4 filed Feb. 14, 2025
- Integral Health Asset Management 2024 Q3 filed Nov. 14, 2024
- Integral Health Asset Management 2024 Q2 filed Aug. 14, 2024
- Integral Health Asset Management 2024 Q1 filed May 15, 2024
- Integral Health Asset Management 2023 Q3 filed Nov. 14, 2023
- Integral Health Asset Management 2023 Q2 filed Aug. 11, 2023
- Integral Health Asset Management 2023 Q1 filed May 9, 2023
- Integral Health Asset Management 2022 Q4 filed Feb. 13, 2023
- Integral Health Asset Management 2022 Q3 filed Nov. 14, 2022
- Integral Health Asset Management 2022 Q2 filed Aug. 3, 2022
- Integral Health Asset Management 2022 Q1 filed May 12, 2022
- Integral Health Asset Management 2021 Q4 filed Feb. 2, 2022